The plasminogen activators, tissue type and urokinase type (tPA and uP
A, respectively) have been identified in human skin under normal condi
tions and in various inflammatory dermatoses, including psoriasis. By
Northern blot analyses, mRNA for uPA, but not for tPA, has been previo
usly identified in epidermal extracts from normal skin, whereas in pso
riasis, mRNA for tPA is readily detected. To further characterize uPA
and tPA expression in psoriasis, the localization of uPA and tPA mRNAs
was evaluated by in situ hybridization. Studies were conducted using
lesional and nonlesional skin of patients with psoriasis as well as no
rmal skin. Additionally, in situ zymography using casein gel overlays
was utilized to assess enzymatic activity. In psoriatic lesional skin,
both uPA and tPA mRNAs were demonstrated by in situ hybridization. Me
ssage for tPA was observed throughout the epidermis with areas of acce
ntuation in the superficial stratum spinosum. Message for uPA was more
focal and was localized primarily in the basal layer. Zymography show
ed tPA activity was coordinately increased in psoriatic lesions. Uninv
olved skin of psoriatic patients was similar to that of normal skin wi
th respect to expression of plasminogen activators. In normal epidermi
s, neither tPA nor uPA mRNA could be detected by in situ hybridization
. Activity for uPA, but not tPA, was observed by zymography. These stu
dies suggest that alterations in plasminogen activators expression may
contribute to the pathogenesis of psoriasis.